No Data
Noile-Immune Biotech: Notice regarding publication of earnings forecasts
Noile-Immune Biotech: Summary of financial results for the 3rd quarter of the fiscal year ending 2024/12 [Japanese GAAP] (unconsolidated)
Asahi, Matsukiyo, Dentsu Group, Lancers (14th) (1379-4990)
※The above calendar is merely a schedule and may be subject to change due to the company's circumstances. --------------------------------------- November 14 (Thursday) <1379> Hokuto <1380> Akikawa Bokuen <142A> Jinjibu <1438> Gifu Landscape <1443> Giken HD <1446> Candiule <1447> SAAF HD <145A> El
Volume change rate ranking (10:00 am) - NEC, KIMOTO, etc. are ranked.
In the volume change rate ranking, you can understand the interests of market participants such as trends in trading by comparing the average volume of the past 5 days with the volume on the delivery day. ■ Top volume change rate [10:32 on October 30] (comparison of average volume of the past 5 days) Stock code Stock name Volume 5-day average volume Volume change rate Stock price change rate ＜7908＞KIMOTO 59854 0118 210.44 282% 0.2663% ＜4893＞NOI
Noile-Immune Biotech: Correction Confirmation Form
Noile-Immune Biotech: Revised Semi-Annual Report - Term 10 (2024/01/01 to 2024/12/31)